5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Enters Into $50M Contract to Supply Tollovid™ and CBD Products to Retail Distributor Company Nerd Hemp
September 22, 2022 16:02 ET | Todos Medical Ltd.
5500 Automated Retail Machines to be Rolled out in Q4/22 and Q1/23 $11.5M in Q4/22 Revenue Expected From This Agreement NEW YORK, NY and TEL AVIV, ISRAEL, Sept. 22, 2022 (GLOBE NEWSWIRE) -- via...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Announces NFL Hall of Famer Michael Irvin as Tollovid™ Sports Ambassador for #TolloUp Campaign
September 16, 2022 07:30 ET | Todos Medical Ltd.
NEW YORK, NY and Tel Aviv, ISRAEL, Sept. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series
August 25, 2022 07:30 ET | Todos Medical Ltd.
Patient denied testing for weeks due to risk of physician infection & non-MSM status Amerimmune Long COVID Panel and Provista research-use-only MonkeyPox assays to assess effect of TPoxx...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Reports Second Quarter 2022 Financial Results and Business Update Conference Call on Tuesday, August 23 at 8:30am ET
August 22, 2022 21:41 ET | Todos Medical Ltd.
Preparations for Tollovir™ Phase 2 Trial Extension to Support EUA Filing Now Complete Preparations for Tollovid™ Phase 2 Trial in Long COVID Now Complete Launch of New Suite of PCR Tests at...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Announces Commercialization of Lesion and Saliva-Based MonkeyPox PCR Testing
August 22, 2022 06:30 ET | Todos Medical Ltd.
Provista begins validation preparations for blood-based IgM/IgG MonkeyPox LDTCompany to release its Q2/2022 10Q quarterly report at 4:05 pm ET this afternoonCompany to host business update conference...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker Panel
July 28, 2022 07:30 ET | Todos Medical Ltd.
NEW YORK, NY, AND TEL AVIV, ISRAEL, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Completes Validation of 27 Pathogen UTI PCR Panel at Its CLIA/CAP Laboratory Provista Diagnostics
June 13, 2022 07:45 ET | Todos Medical Ltd.
NEW YORK, NY and TEL AVIV, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical to Present at the Proactive One2One Virtual Forum
March 17, 2022 07:00 ET | Todos Medical Ltd.
- Thursday, March 17, 2022 at 2:00 PM – 2:30 PM ET - NEW YORK, NY and Tel Aviv, ISRAEL, March 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Completes Acquisition of Key Assets and Intellectual Property from NLC Pharma
March 16, 2022 07:00 ET | Todos Medical Ltd.
- Forms new subsidiary, 3CL Pharma, focused on the development and commercialization of 3CL protease-related products including Tollovir™, Tollovid®, Tollovid Daily™ and TolloTest™ for COVID-19 - ...
5e70ba2109b32d0004a916bd_1.jpg
Todos Medical Announces Tollovid® Products Exclusive License & Distribution Agreement with T-Cell Protect Hellas S.A. Covering 30 Countries in Europe
November 18, 2021 06:00 ET | Todos Medical Ltd.
The Agreement Calls for a Minimum of 500,000 Bottles in Sales Over 18 Months T-Cell Protect to Invest 1 Million Euros in Todos to Support Development of Tollovir, the Company’s 3CL Protease...